Since sarcopenia is strongly associated with morbidity and mortality [160], there is a great need for investigation of nutrition and exercise strategies as well as novel pharmacotherapies aimed to preserve muscle mass and function during incretin analog therapy [158,161]. Here, GCG is linked to sarcopenia.